Business Context and Reporting Period
This Form 8-K reports on the 2019 Annual Meeting of Stockholders held by GlycoMimetics, Inc. on May 17, 2019. The registrant is an emerging growth company incorporated in Delaware with its principal executive offices in Rockville, MD. The filing details the voting results for two proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes rather than financial performance.
Material Changes and Voting Results
Of the 43,168,969 shares outstanding, 41,008,122 shares (94.99%) were present or represented by proxy. The results for the proposals were as follows:
- Proposal 1: Election of Directors
- Scott Jackson: Elected with 36,450,253 votes for and 741,989 votes withheld.
- Scott Koenig, M.D., Ph.D.: Elected with 17,915,656 votes for and 19,276,586 votes withheld.
- Broker Non-Votes: 3,815,880.
- Proposal 2: Ratification of Auditors
- Ernst & Young LLP: Ratified with 40,973,117 votes for, 13,120 votes against, and 21,885 abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves solely to disclose the results of the shareholder vote.
Investor Verification Checklist
- Verify the significant number of votes withheld for director nominee Scott Koenig (approximately 52% of votes cast on that specific proposal).
- Confirm the total share count and proxy participation rate (94.99%) against the definitive proxy statement filed on April 10, 2019.
- Review the Company's subsequent filings for financial data, as this 8-K contains no financial metrics.